Menu
Not yet recruiting NCT07578194

Coercive Control and Intimate Partner Violence

No phase Interventional Coercive Control

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: questionnaire.
Who it may be relevant to
Registry conditions: Coercive Control. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Coercive Control and Intimate Partner Violence: Examining the Relationships Between Exposure to Violence and Victims' Physical and Mental Health Outcomes

Overview

Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care. The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.

Interventions

  • Other questionnaire
    Participants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment

Primary outcome measures

  • Coercive Control Screening Scale [Time frame: Measure of CCSS between inlusion and month 6]
Secondary outcome measures (8)
  • Measure of Hospital Anxiety and Depression scale (HAD scale) [Time frame: Measure of HHAD scale between inclusion and month 6]
  • Severity of post-traumatic stress disorder symptoms [Time frame: at inclusion and month 6]
  • International Trauma Questionnaire (ITQ). [Time frame: Inclusion and month 6]
  • Severity of emotional dysregulation [Time frame: inclusion and month 6]
  • Short Form Health Survey (SF-12) [Time frame: inclusion and month 6]
  • Brief Pain Inventory [Time frame: at inclusion and month 6]
  • Coercive Control Scale (CCSS) [Time frame: inclusion and month 6]
  • Woman Abuse Screening Tool (WAST) [Time frame: inclusion and month 6]

Eligibility criteria

Inclusion criteria

  • Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).
  • Women identified as victims of intimate partner violence.
  • Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.
  • No objection to participation in the study (non-opposition).
  • Affiliation with a French social security scheme or eligibility for universal health coverage (Couverture Maladie Universelle, CMU).

Exclusion criteria

  • Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.
  • Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.
  • Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • CHI Robert Ballanger — Aulnay-sous-Bois

Identifiers

NCT: NCT07578194 · GHT GPNE

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗